Alkermes plc - Ordinary Shares (ALKS): Price and Financial Metrics
ALKS Price/Volume Stats
| Current price | $30.71 | 52-week high | $36.45 |
| Prev. close | $30.84 | 52-week low | $22.90 |
| Day low | $30.38 | Volume | 80,008 |
| Day high | $31.04 | Avg. volume | 1,757,650 |
| 50-day MA | $31.11 | Dividend yield | N/A |
| 200-day MA | $29.70 | Market Cap | 5.06B |
ALKS Stock Price Chart Interactive Chart >
Alkermes plc - Ordinary Shares (ALKS) Company Bio
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 and is based in Dublin, Ireland.
ALKS Price Returns
| 1-mo | 11.51% |
| 3-mo | -14.69% |
| 6-mo | 8.94% |
| 1-year | 25.40% |
| 3-year | 14.25% |
| 5-year | 101.11% |
| YTD | 6.78% |
| 2024 | 3.68% |
| 2023 | 6.16% |
| 2022 | 12.34% |
| 2021 | 16.59% |
| 2020 | -2.21% |
Continue Researching ALKS
Want to see what other sources are saying about Alkermes plc's financials and stock price? Try the links below:Alkermes plc (ALKS) Stock Price | Nasdaq
Alkermes plc (ALKS) Stock Quote, History and News - Yahoo Finance
Alkermes plc (ALKS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...